{"id":49599,"date":"2023-08-09T00:06:04","date_gmt":"2023-08-08T21:06:04","guid":{"rendered":"https:\/\/kutaybilen.com.tr\/?p=49599"},"modified":"2023-08-09T00:06:04","modified_gmt":"2023-08-08T21:06:04","slug":"chp-milletvekili-bulut-sma-hastalarinin-ilaca-ulasamamasini-meclis-gundemine-tasidi","status":"publish","type":"post","link":"https:\/\/kutaybilen.com.tr\/?p=49599","title":{"rendered":"CHP Milletvekili Bulut, SMA hastalar\u0131n\u0131n ilaca ula\u015famamas\u0131n\u0131 Meclis g\u00fcndemine ta\u015f\u0131d\u0131"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/i.hbrcdn.com\/haber\/2023\/08\/08\/burhanettin-bulut-tan-fahrettin-koca-ya-sma-16205669_amp.jpg\" \/><\/p>\n<p>CHP Adana Milletvekili Burhanettin Bulut, SMA hastalar\u0131n\u0131n T\u00fcrkiye&#8217;de ruhsatl\u0131 tek ilac\u0131 olan &#8216;Spinraza&#8217;ya 3 ayd\u0131r ula\u015famamas\u0131n\u0131 Meclis g\u00fcndemine ta\u015f\u0131d\u0131. Bulut, S\u0131hhat Bakan\u0131 Fahrettin Koca&#8217;ya &#8220;SMA hastalar\u0131n\u0131n geri \u00f6deme kapsam\u0131nda tek ilac\u0131 olan Spinraza&#8217;n\u0131n 3 ayd\u0131r bulunamama m\u00fcnasebeti nedir? SMA hastalar\u0131 ve aileleri yazg\u0131lar\u0131na mi terk edilmi\u015ftir&#8221; diye sordu.<\/p>\n<p>CHP Adana Milletvekili Burhanettin Bulut, Spinal M\u00fcsk\u00fcler Atrofi (SMA) hastalar\u0131n\u0131n meselelerini Meclis g\u00fcndemine ta\u015f\u0131d\u0131. S\u0131hhat Bakan\u0131 Fahrettin Koca&#8217;n\u0131n yan\u0131tlamas\u0131 istemiyle TBMM Ba\u015fkanl\u0131\u011f\u0131&#8217;na soru \u00f6nergesi veren Bulut, T\u00fcrkiye&#8217;de, genetik bir kas hastal\u0131\u011f\u0131 olan SMA&#8217;dan etkilenen yakla\u015f\u0131k 3 bin ki\u015finin bulundu\u011funu belirtti. Bulut, \u015funlar\u0131 kaydetti: <\/p>\n<p><strong>&#8220;SA\u011eLIK BAKANLI\u011eI \u0130LACA NE VAK\u0130T ULA\u015eILACA\u011eINA A\u0130T RASTGELE B\u0130R A\u00c7IKLAMA YAPMAMAKTA&#8221;<\/strong> <\/p>\n<p>&#8220;Her ya\u015fta ortaya \u00e7\u0131kabilen, ilerleyici ve \u00f6l\u00fcmc\u00fcl bir hastal\u0131k olarak tan\u0131mlanan SMA&#8217;n\u0131n d\u00fcnyada g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 10 binde bir iken, T\u00fcrkiye&#8217;de 6 binde. 3 farkl\u0131 ilac\u0131 bulunan SMA&#8217;n\u0131n, T\u00fcrkiye&#8217;de tek ruhsatl\u0131 ilac\u0131, 2017 y\u0131l\u0131ndan bu yana \u00fclkemizde geri \u00f6deme kapsam\u0131nda olan Spinraza isimli ila\u00e7t\u0131r. Lakin aileler 3 ayd\u0131r bu ilaca ula\u015famamaktad\u0131r. S\u0131hhat Bakanl\u0131\u011f\u0131 ilaca ne vakit ula\u015f\u0131laca\u011f\u0131na ait rastgele bir a\u00e7\u0131klama yapmamakta, bu durum \u00e7ocuklar\u0131 daima kas kayb\u0131na u\u011frayan, s\u0131hhat durumu berbatla\u015fan aileleri \u00fcmitsizli\u011fe sevk etmektedir.<\/p>\n<p><strong>&#8220;\u0130LA\u00c7LAR GER\u0130 \u00d6DEME KAPSAMINA ALINACAK MI?&#8221;<\/strong> <\/p>\n<p>Sa\u011fl\u0131k Bakan\u0131 Koca, 2023 y\u0131l\u0131 S\u0131hhat Bakanl\u0131\u011f\u0131 b\u00fct\u00e7e g\u00f6r\u00fc\u015fmelerinde, &#8216;Bilim \u015euras\u0131&#8217;n\u0131n oral kullan\u0131m\u0131 olan ikinci bir ilac\u0131n kullan\u0131m\u0131n\u0131 onaylad\u0131\u011f\u0131n\u0131, ilac\u0131n kullan\u0131ma al\u0131naca\u011f\u0131&#8217; istikametindeki a\u00e7\u0131klamalar\u0131n\u0131 mevcut. Ortadan 8 aydan fazla m\u00fchlet ge\u00e7mesine kar\u015f\u0131n ila\u00e7 \u015fimdi ruhsatland\u0131r\u0131lmam\u0131\u015f ve geri \u00f6deme kapsam\u0131na al\u0131nmam\u0131\u015ft\u0131r. Devletin en temel vazifesi insan\u0131 ya\u015fatmakt\u0131r. SMA&#8217;l\u0131 bebekler, ailelerin kendi imkanlar\u0131 \u00e7er\u00e7evesinde d\u00fczenledi\u011fi kampanyalarla de\u011fil; devletin y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc olarak ya\u015fat\u0131lmak zorundad\u0131r. SMA hastalar\u0131n\u0131n ailelerinin talebi, Spinraza isimli ilac\u0131n d\u0131\u015f\u0131nda, oral kullan\u0131m avantaj\u0131 olan Risdiplam ile tek seferlik uygulama avantaj\u0131 olan ve sa\u011flam SMN-1 geninin transferini sa\u011flayan Zolgensma&#8217;n\u0131n da geri \u00f6deme kapsam\u0131na al\u0131nmas\u0131d\u0131r.<\/p>\n<p><strong>&#8220;\u0130LA\u00c7 3 AYDIR NEDEN YOK?&#8221;<\/strong> <\/p>\n<p>Bulut, S\u0131hhat Bakan\u0131 Koca&#8217;ya \u015fu sorular\u0131 y\u00f6neltti: <\/p>\n<p>&#8220;-SMA hastalar\u0131n\u0131n geri \u00f6deme kapsam\u0131nda tek ilac\u0131 olan Spinraza&#8217;n\u0131n 3 ayd\u0131r bulunamama gerekesi nedir?<\/p>\n<p>-SMA hastalar\u0131 ve aileleri yazg\u0131lar\u0131na mi terk edilmi\u015ftir?<\/p>\n<p>-SMA hastalar\u0131n\u0131n umutla bekledi\u011fi oral kullan\u0131m avantaj\u0131 olan ila\u00e7la ilgili geli\u015fmeler ne istikamettedir? \u0130la\u00e7 \u00fclkemizde ne vakit ruhsat alacakt\u0131r?<\/p>\n<p><strong>&#8220;SMA \u0130LACI NE VAK\u0130T RUHSATLANDIRILACAK?&#8221;<\/strong> <\/p>\n<p>-A\u00e7\u0131klaman\u0131z\u0131n \u00fczerinden 8 aydan fazla ge\u00e7mesine ra\u011fmen ruhsat s\u00fcreci neden sonu\u00e7land\u0131r\u0131lmam\u0131\u015f ve geri \u00f6deme kapsam\u0131na al\u0131narak hastalar\u0131n kullan\u0131m\u0131na sunulmam\u0131\u015ft\u0131r?<\/p>\n<p>-SMA hastalar\u0131 i\u00e7in Spinraza ilac\u0131 i\u00e7in yap\u0131lan toplam harcama \u00f6l\u00e7\u00fcs\u00fc ne kadard\u0131r? Hangi hasta tipi i\u00e7in ba\u015fka farkl\u0131 ne \u00f6l\u00e7\u00fcde hastane, tedavi ve ila\u00e7 masraf\u0131 yap\u0131lm\u0131\u015ft\u0131r?<\/p>\n<p>-Zolgensma ilac\u0131n\u0131n devlet taraf\u0131ndan fiyats\u0131z kar\u015f\u0131lanmas\u0131 yahut i\u015ftirak hisseli bir b\u00fct\u00e7e olu\u015fturulmas\u0131 i\u00e7in rastgele bir \u00e7al\u0131\u015fma yap\u0131lmakta m\u0131d\u0131r?<\/p>\n<div>Kaynak: ANKA \/  S\u0131hhat <\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHP Adana Milletvekili Burhanettin Bulut, T\u00fcrkiye&#8217;de ruhsatl\u0131 tek ila\u00e7 olan &#8216;Spinraza&#8217;ya 3 ayd\u0131r ula\u015famayan SMA hastalar\u0131n\u0131n durumunu Meclis g\u00fcndemine ta\u015f\u0131d\u0131. Bulut, S\u0131hhat Bakan\u0131 Fahrettin Koca&#8217;ya sorular y\u00f6neltti ve ilac\u0131n ne vakit ruhsatland\u0131r\u0131laca\u011f\u0131n\u0131 sordu.<\/p>\n","protected":false},"author":1,"featured_media":49600,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[6974,4731,6226,68,6973],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/49599"}],"collection":[{"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49599"}],"version-history":[{"count":1,"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/49599\/revisions"}],"predecessor-version":[{"id":49601,"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/49599\/revisions\/49601"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=\/wp\/v2\/media\/49600"}],"wp:attachment":[{"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kutaybilen.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}